SMDG to Present at Oxford Global Discovery & Development Europe 2026

 

SMDG is pleased to announce its participation in the Discovery & Development Europe 2026, taking place on 15–16 June 2026. The event will bring together more than 1,000 leaders from biotech, pharma, and academia to explore the latest innovations accelerating drug discovery and development.

​

As part of the scientific programme, Dr. Shadi Farhangrazi will present SMDG’s work on advancing genetic medicine therapeutics for rare pediatric diseases. Her talk will highlight the company’s proprietary platforms and their potential to overcome long-standing barriers in targeted gene-based therapies.

​

​​​

June 2026 

 

SMDG will be attending UK Biotech Day 2026 in London on May 27–28, 2026

 

As one of the UK’s leading gatherings for biotech innovators, investors, and pharmaceutical leaders, the event brings together the global life sciences community to drive partnerships, deal-making, and scientific advancement.

​

​SMDG looks forward to engaging with partners, investors, and collaborators to showcase its proprietary platform technologies and discuss opportunities in CNS drug delivery, oncology, and inflammatory diseases.

​

May 2026 

 

Dr. Shadi Farhangrazi will be speaking at the Westminster Health Forum on 15 May 2026 as part of a session on advancing women’s health across research, development, and innovation.

​

Joining a panel of experts from across healthcare, research, and industry, she will focus on the diagnosis and treatment of neurological and inflammatory diseases in women — addressing critical gaps in research, representation in clinical trials, and the development of effective therapies.

​

Dr. Farhangrazi will also share insights from SMDG's latest research and highlight the urgent need for greater investment in women’s health to drive innovation and improve outcomes.

​

May 2026